Global Antibiotic Research & Development Partnership, North America (Gardp Na)

Not-for-profit focused on developing treatments for drug-resistant infections

Based in DE

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $0 in lobbying spend across 3 quarterly filings, Global Antibiotic Research & Development Partnership, North America (Gardp Na) is an active lobbying client. Their lobbying covers 1 issue area. Active from 2021 to 2022.

$0
Total Spend
2
Years Active
1
Firms Hired
2
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2021$0
2022$0

Issues Lobbied

MED

Lobbying Firms

Faegre Drinker Biddle & Reath LLP

Lobbyists

Jodie CurtisLaura Hanen

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED

Antibiotic research and development and antimicrobial resistance

Antibiotic research and development; CURES 2.0; S.2076, H.R. 3932 - PASTEUR Act.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Guarding Against Pandemics, INC.
$2.0M total spend
Nrx Pharmaceuticals INC (Formerly Known as Neurorx)
$754K total spend
Labware, INC.
$390K total spend
1day Sooner Action Project
$320K total spend
Amivas, LLC
$100K total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.